Clinical Trials
20
Active:4
Completed:8
Trial Phases
5 Phases
Phase 1:9
Phase 2:3
Phase 3:2
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials
Phase 1
9 (45.0%)Phase 4
4 (20.0%)Phase 2
3 (15.0%)Not Applicable
2 (10.0%)Phase 3
2 (10.0%)PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)
Phase 2
Recruiting
- Conditions
- Rotavirus Gastroenteritis
- Interventions
- Biological: Oral hexavalent reassortant rotavirus attenuated live vaccineBiological: Oral pentavalent reassortant rotavirus attenuated live vaccine (controlled)
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Sinovac Life Sciences Co., Ltd.
- Target Recruit Count
- 400
- Registration Number
- NCT06967272
- Locations
- 🇨🇳
Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China
Clinical Trial on the Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)
Phase 1
Active, not recruiting
- Conditions
- Rotavirus Gastroenteritis
- Interventions
- Biological: Oral hexavalent reassortant rotavirus attenuated live vaccineBiological: Placebo
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Sinovac Life Sciences Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06950645
- Locations
- 🇨🇳
Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei, China
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
Phase 1
Not yet recruiting
- Conditions
- Tetanus
- Interventions
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Sinovac Life Sciences Co., Ltd.
- Target Recruit Count
- 255
- Registration Number
- NCT06939777
- Locations
- 🇨🇳
The Second Hospital of Anhui Medical University, Hefei, Anhui, China
Clinical Trial of PCV24 in Infants Aged 2-23 Months
Phase 1
Not yet recruiting
- Conditions
- Pneumococcal Infectious Disease
- Interventions
- Biological: Sinovac PCV24Biological: Prevnar®
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Sinovac Life Sciences Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT06800261
- Locations
- 🇨🇳
Shandong Provincial Center for Disease Control and Prevention, Jinan, Shandong, China
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
Phase 3
Recruiting
- Conditions
- Pneumococcal Infectious Disease
- Interventions
- Biological: Sinovac PCV13Biological: Prevnar®
- First Posted Date
- 2024-09-27
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Sinovac Life Sciences Co., Ltd.
- Target Recruit Count
- 3080
- Registration Number
- NCT06617715
- Locations
- 🇨🇳
Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found